<

Zirgan (ganciclovir ophthalmic gel) 0.15%



Important Safety Information | Prescribing Information




PRESCRIPTION SAVINGS PROGRAM


Instant Savings Offer

Savings up to $35 off for eligible commercially insured patients and up to $150 off for eligible uninsured patients.*
Exclusively at Walgreens and other participating independent pharmacies. 

Click below for program:

If you have any questions regarding your eligibility or benefits, please call 1-855-280-0580.

*Terms and conditions apply. Please see bauschaccessprogram.com for eligibility criteria and terms and conditions. This offer is only valid for patients with commercial insurance and eligible uninsured patients.This offer is not valid for any person eligible for reimbursement of prescriptions, in whole or in part, by any federal, state, or other governmental programs, including, but not limited to, Medicare (including Medicare Advantage and Part A, B, and D plans), Medicaid, TRICARE, Veterans Administration or Department of Defense health coverage, CHAMPUS, the Puerto Rico Government Health Insurance Plan, or any other federal or state health care programs. This offer is good only in the U.S. at retail pharmacies owned and operated by Walgreen Co. (or its affiliates) or other participating independent retail pharmacies. This offer is not valid in Massachusetts or Minnesota or where otherwise prohibited, taxed or otherwise restricted. Click here for all eligibility criteria and terms and conditions that apply.



Indication

ZIRGAN (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).

Important Safety Information

  • ZIRGAN is indicated for topical ophthalmic use only.

  • Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with ZIRGAN.

  • Most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%).

  • Safety and efficacy in pediatric patients below the age of 2 years have not been established.

Click here for Prescribing Information about ZIRGAN.


Zirgan is a trademark of Laboratoires Théa Corporation used under license.

ZGN.0015.USA.17